PIK3CA and Miyoshi myopathy: The genetic mechanisms underlying this oncogenic deregulation in MM are not entirely clear as some of the lesions that could potentially be involved, such as PIK3CA mutation or PTEN deletion, are too rare in this disease to be held fully accountable [16].